Scarica l'app Stockscreener
17.20
1.09%
-0.19
Dopo l'orario di chiusura:
17.54
0.34
+1.98%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BHVN Giù?
Forum
Previsione
Precedente Chiudi:
$17.39
Aprire:
$17.2
Volume 24 ore:
2.43M
Relative Volume:
1.09
Capitalizzazione di mercato:
$1.82B
Reddito:
-
Utile/perdita netta:
$-766.97M
Rapporto P/E:
-2.2454
EPS:
-7.66
Flusso di cassa netto:
$-646.43M
1 W Prestazione:
+3.61%
1M Prestazione:
+14.59%
6M Prestazione:
-22.24%
1 anno Prestazione:
-65.43%
Intervallo 1D:
$16.90
$17.84
Intervallo di 1 settimana:
$16.80
$18.57
Portata 52W:
$12.79
$54.98
Biohaven Ltd Stock (BHVN) Company Profile
Nome
Biohaven Ltd
Settore
Industria
Telefono
203-404-0410
Indirizzo
215 CHURCH STREET, NEW HAVEN, CT
Confronta BHVN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BHVN
Biohaven Ltd
|
17.20 | 1.84B | 0 | -766.97M | -646.43M | -7.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Biohaven Ltd Stock (BHVN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Iniziato | Citigroup | Buy |
| 2025-09-03 | Iniziato | Raymond James | Strong Buy |
| 2025-05-19 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-09-16 | Iniziato | Jefferies | Buy |
| 2024-09-04 | Iniziato | Bernstein | Outperform |
| 2024-07-24 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-16 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-02-06 | Iniziato | UBS | Buy |
| 2023-12-22 | Iniziato | H.C. Wainwright | Buy |
| 2023-12-08 | Iniziato | Robert W. Baird | Outperform |
| 2023-01-24 | Iniziato | SVB Securities | Outperform |
| 2023-01-04 | Iniziato | JP Morgan | Overweight |
| 2022-12-02 | Iniziato | BTIG Research | Buy |
| 2022-10-26 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2022-10-12 | Iniziato | Piper Sandler | Overweight |
| 2022-08-19 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-08-08 | Downgrade | Wedbush | Outperform → Neutral |
| 2022-05-11 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-19 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-08-10 | Downgrade | UBS | Buy → Neutral |
| 2021-08-03 | Reiterato | Canaccord Genuity | Buy |
| 2021-03-11 | Iniziato | UBS | Buy |
| 2020-12-15 | Iniziato | H.C. Wainwright | Buy |
| 2020-04-17 | Iniziato | Cowen | Outperform |
| 2020-02-10 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-02-06 | Iniziato | Mizuho | Buy |
| 2019-11-22 | Iniziato | Wedbush | Outperform |
| 2019-06-25 | Reiterato | Canaccord Genuity | Buy |
| 2019-05-06 | Iniziato | Goldman | Buy |
| 2019-04-09 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-03-04 | Reiterato | Needham | Buy |
| 2018-07-03 | Reiterato | Needham | Buy |
| 2018-07-02 | Reiterato | Needham | Buy |
| 2018-04-05 | Downgrade | Barclays | Overweight → Equal Weight |
| 2018-02-22 | Reiterato | Canaccord Genuity | Buy |
| 2017-12-15 | Iniziato | Canaccord Genuity | Buy |
| 2017-10-03 | Reiterato | Needham | Buy |
Mostra tutto
Biohaven Ltd Borsa (BHVN) Ultime notizie
Has Biohaven Ltd. formed a bullish divergenceEarnings Performance Report & Risk Controlled Stock Pick Alerts - newser.com
Will Biohaven Ltd. stock gain from government policies2025 Market Sentiment & Safe Entry Zone Tips - newser.com
Is a relief rally coming for Biohaven Ltd. holdersJuly 2025 News Drivers & Intraday High Probability Setup Alerts - newser.com
How cyclical is Biohaven Ltd. Common Shares stock compared to rivalsJuly 2025 Summary & Comprehensive Market Scan Reports - newser.com
Biohaven Ltd. (NYSE:BHVN) institutional owners may be pleased with recent gains after 66% loss over the past year - Yahoo Finance
How Biohaven Ltd. Common Shares stock trades in high volatilityTrend Reversal & AI Forecast Swing Trade Picks - newser.com
Earnings visualization tools for Biohaven Ltd.2025 Buyback Activity & Stepwise Entry and Exit Trade Signals - newser.com
Biohaven Ltd. stock chart pattern explainedQuarterly Trade Review & Capital Efficient Trading Techniques - newser.com
Relative strength of Biohaven Ltd. in sector analysisJuly 2025 Selloffs & Short-Term High Return Strategies - newser.com
Is Biohaven Ltd. Common Shares stock a contrarian opportunityJuly 2025 PreEarnings & Risk Controlled Daily Plans - newser.com
Will Biohaven Ltd. stock remain a Wall Street favoriteEarnings Risk Summary & Weekly Top Gainers Alerts - newser.com
Will Biohaven Ltd. stock maintain momentum in 20252025 Retail Activity & Long-Term Growth Stock Strategies - newser.com
Market reaction to Biohaven Ltd.’s recent newsJuly 2025 Closing Moves & Daily Momentum Trading Reports - newser.com
Predicting Biohaven Ltd. trend using moving averagesPortfolio Growth Summary & Growth-Oriented Investment Plans - newser.com
Emerald Mutual Fund Advisers Trust Has $2.44 Million Stock Holdings in Biohaven Ltd. $BHVN - MarketBeat
Emerald Advisers LLC Sells 33,944 Shares of Biohaven Ltd. $BHVN - MarketBeat
Signal strength of Biohaven Ltd. stock in tech scannersTrade Analysis Report & Long-Term Safe Return Strategies - newser.com
Biohaven Ltd. stock trend outlook and recovery pathWeekly Investment Summary & Fast Moving Trade Plans - newser.com
Why retail investors pile into Biohaven Ltd. stockTrade Volume Report & Weekly Stock Breakout Alerts - newser.com
Vanguard holds 2,875,190 Biohaven shares; 2.71% of class - Stock Titan
Biohaven Ltd. $BHVN Shares Acquired by Y Intercept Hong Kong Ltd - MarketBeat
Will Biohaven Ltd. stock gain from strong economyJuly 2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - newser.com
Spinocerebellar Ataxias Clinical Landscape, Companies, Therapeutic Evaluation, Therapies, Treatment Framework, and Pipeline Analysis | Biohaven Pharmaceuticals, Steminent US, Vico Therapeutics B.V., A - Barchart.com
Biohaven Ltd Azioni (BHVN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):